Literature DB >> 15851840

The effects of Chinese herb Angelica in focal cerebral ischemia injury in the rat.

Jing Wei Yang1, Jing Ping Ouyang, Wei Jing Liao, Jun Tian, Yong Ming Liu, Lei Wei, Bao Hua Wang, Ke Li.   

Abstract

This experiment was designed to study the therapeutic mechanisms of Angelica on the focal cerebral ischemia injury of the rat. The ischemic area was determined by TTC stain. And terminal deoxynucleotidyl transferase (TDT) mediated DUTP-biotin nick end labeling (TUNEL) method was applied to detect neuronal apoptosis. The expressions of Bcl-2 and Bax proteins were observed by immunohistochemical staining methods. Results show that the treatment with angelica reduced the volume of cerebral infarction (p < 0.05), and that the number of neuronal apoptosis cells decreased significantly (p < 0.01). Also the expression level of Bax protein decreased (p < 0.01). These results suggest that Angelica can reduce the number of apoptosis cells by decreasing the expression of Bax protein. This is maybe one of the mechanisms of the therapeutic effect of Angelica on focal cerebral ischemia injury.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15851840

Source DB:  PubMed          Journal:  Clin Hemorheol Microcirc        ISSN: 1386-0291            Impact factor:   2.375


  2 in total

Review 1.  Neuroprotection by spice-derived nutraceuticals: you are what you eat!

Authors:  Ramaswamy Kannappan; Subash Chandra Gupta; Ji Hye Kim; Simone Reuter; Bharat Bhushan Aggarwal
Journal:  Mol Neurobiol       Date:  2011-03-01       Impact factor: 5.590

2.  Pretreated Glehnia littoralis Extract Prevents Neuronal Death Following Transient Global Cerebral Ischemia through Increases of Superoxide Dismutase 1 and Brain-derived Neurotrophic Factor Expressions in the Gerbil Hippocampal Cornu Ammonis 1 Area.

Authors:  Joon Ha Park; Tae-Kyeong Lee; Bing-Chun Yan; Bich-Na Shin; Ji Hyeon Ahn; In Hye Kim; Jeong Hwi Cho; Jae-Chul Lee; In Koo Hwang; Jong Dai Kim; Seongkweon Hong; Young Joo Lee; Moo-Ho Won; Il Jun Kang
Journal:  Chin Med J (Engl)       Date:  2017-08-05       Impact factor: 2.628

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.